Scienture reports preliminary Q3 2026 revenue of $1.22 million, up sharply on Rezenopy launchOct 19Quarterly updatelosartannaloxone
Scienture launches REZENOPY, cites patent wins and payer gains in Q2 2026 updateAug 20Quarterly updatenaloxoneScienture Holdings, Inc.